Construction has stopped on a pharmaceutical facility being built with a $6 million loan from a suburban Indianapolis city.
Greenwood city attorney Krista Taggart says the city could foreclose on the Elona Biotechnologies facility within the next few weeks unless new investors take over the company. Taggart tells the Daily Journal in Franklin that the city is exploring all its options for the facility near Interstate 65 where insulin was to be produced.
Greenwood officials three years ago approved $8.4 million of incentives for the project, including the construction loan. Elona said then it expected to employ some 70 workers and spend more than $25 million on a planned expansion.
Elona told Greenwood officials of financial troubles in late January. In February, the company said that it had reached a deal under which the company would be acquired by private investors.
The newspaper reports the company founders didn't return messages and that its phone number has been disconnected.